Clinical Trial Update: Rucaparib in Combination With Nivolumab in Patients With Advanced or Metastatic Biliary Tract Cancer Following Platinum Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of rucaparib and nivolumab in patients with advanced or metastatic biliary tract cancer who have progressed after plati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• OPDIVO (nivolumab)
• RUBRACA (RUCAPARIB)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Biliary Tract Cancer | Phase 2 | Status: COMPLETED | Results posted: 2024-08-21